News Blog

In Neurogenetics, Hoofbeats Mean Zebras, Not Horses

In 2019, the first gene therapy treatment for a neurogenetic disease was approved for SMA. This therapy is just the beginning, and it’s marked a tipping point in genomic analysis as it reshapes the field of neurology.

On the News Blog

Penn Medicine In the News

  • Patients Who Use Online Portals More Likely to Get Flu Shot, Penn Study Finds

    October 09, 2019
  • Neuroscientists: Heart Disease and Diabetes Are Adaptations

    October 02, 2019
  • Netflix’s ‘Diagnosis’ and the Ethical Perils of Medical Crowdsourcing

    September 25, 2019
Share This Page: